Evaluation of BRCA1/2 mutation prevalence in Korean women with triple-negative breast cancer

被引：0
|
作者：
Lee, A. S. [1 ]
Kang, E. Y. [1 ]
Baek, H. [1 ]
Chae, S. [1 ]
Kim, E-K. [1 ]
Kim, S. W. [2 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Breast Care Ctr, Songnam, South Korea
[2] Daerim St Marys Hosp, Surg, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54O
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [31] Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis
    Tun, N. M.
    Villani, G.
    Ong, K.
    Yoe, L.
    Bo, Z. M.
    [J]. CLINICAL GENETICS, 2014, 85 (01) : 43 - 48
  • [32] High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients
    Rashid, Muhammad Usman
    Muhammad, Noor
    Bajwa, Seerat
    Faisal, Saima
    Tahseen, Muhammad
    Bermejo, Justo Lorenzo
    Amin, Asim
    Loya, Asif
    Hamann, Ute
    [J]. BMC CANCER, 2016, 16
  • [33] High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients
    Muhammad Usman Rashid
    Noor Muhammad
    Seerat Bajwa
    Saima Faisal
    Muhammad Tahseen
    Justo Lorenzo Bermejo
    Asim Amin
    Asif Loya
    Ute Hamann
    [J]. BMC Cancer, 16
  • [34] The BRCA1 promoter methylation is one of the mechanisms of th BRCA1 dysfunction of triple-negative breast cancer
    Yamashita, N.
    Tokunaga, E.
    Tanaka, K.
    Saeki, H.
    Oki, E.
    Kitao, H.
    Morita, M.
    Maehara, Y.
    [J]. CANCER RESEARCH, 2013, 73
  • [35] Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study
    Fujisawa, Fumie
    Tamaki, Yasuhiro
    Inoue, Tazuko
    Nakayama, Takahiro
    Yagi, Toshinari
    Kittaka, Nobuyoshi
    Yoshinami, Tetsuhiro
    Nishio, Minako
    Matsui, Saki
    Kusama, Hiroki
    Kamiura, Shoji
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (05)
  • [36] BRCA1 methylation contributes to the triple-negative breast cancer phenotype.
    Nwachukwu, C.
    Grushko, T. A.
    Xu, J.
    Khramtsov, A.
    Olopade, O., I
    [J]. CANCER RESEARCH, 2009, 69 (02) : 266S - 266S
  • [37] Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
    Abdel-Razeq, Hikmat
    Tamimi, Faris
    Abujamous, Lama
    Edaily, Sara
    Abunasser, Mahmoud
    Bater, Rayan
    Salama, Osama
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4597 - 4604
  • [38] The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China
    Yong Tao Li
    Duo Ni
    Liang Yang
    Qian Zhao
    Jiang Hua Ou
    [J]. European Journal of Medical Research, 19
  • [39] Triple-negative breast cancer and BRCA mutation: looking at the future
    Ballatore, Z.
    Pistelli, M.
    Bracci, R.
    Bianchi, F.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    De Lisa, M.
    Della Mora, A.
    Cantini, L.
    Bastianelli, L.
    Pagliacci, A.
    Battelli, N.
    Berardi, R.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [40] Triple-negative breast cancer and BRCA mutation: looking at the future
    Ballatore, Z.
    Pistelli, M.
    Bracci, R.
    Bianchi, F.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    De Lisa, M.
    Della Mora, A.
    Cantini, L.
    Bastianelli, L.
    Pagliacci, A.
    Battelli, N.
    Berardi, R.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345